Rhodiola rosea (R. rosea), also known as roseroot, may be an effective antidepressant that is safer and better tolerated than sertraline.
Japanese regulators have approved AbbVie's Viekirax to treat patients with genotype 1 chronic hepatitis C, including those with compensated cirrhosis, the most common type of hepatitis in that country.
Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia features once-monthly and six-week dosing options.
California's Gov. Jerry Brown signed a controversial law permitting physicians to prescribe lethal doses of drugs in cases where a patient has six months or less to live.
The US Food and Drug Administration today approved combining ambrisentan (Letairis/Gilead) with tadalafil to treat pulmonary arterial hypertension.
The hallmark degenerative process in spinal cord injury may be caused by lysophosphatidic acid, the lipid that acts as a signal between various cells, according to findings published in The Journal of Neuroscience.
The FDA approved a new bioabsorbable polymer drug-eluting stent system for coronary artery disease.
There is a positive association of measures of pulmonary function with lipoprotein a [Lp(a)] in older adults who live in a community setting, according to a recent study.
Incidences of inflammatory bowel disease (IBD) have grown in patients also suffering from autism spectrum disorders (ASD), a neurocognitive disorder characterized by an impaired ability to communicate and interact.